First Patient in �鶹��ý�� Receives New Therapy for Delay of T1D Onset at the BDC

BDC Announcements

BDC in the News

First Patient in �鶹��ý�� Receives New Therapy for Delay of T1D Onset at the BDC

New Therapy First to Target Type 1 Diabetes Disease Process

Apr 17, 2023

For more information on screening and onset of T1D, see , a program run by the BDC.

Tzield, which was approved by the FDA in 2022, is the first drug on the market indicated to delay the full onset of Type 1 Diabetes. This novel drug is available for patients in Stage-2 Type 1 Diabetes as a 1-day infusion series. As part of its ongoing commitment diabetes treatment and prevention, the Barbara Davis Center was the first site in �鶹��ý�� to infuse a patient with Tzield. The Center's new Early T1D Clinic now offer this therapy in addition to screening, monitoring, long-term follow-up, and education as patients navigate the onset of T1D.

First Patient in �鶹��ý�� Receives New Therapy for Delay of T1D Onset at the BDC

New Therapy First to Target Type 1 Diabetes Disease Process

Apr 17, 2023

For more information on screening and onset of T1D, see , a program run by the BDC.

Tzield, which was approved by the FDA in 2022, is the first drug on the market indicated to delay the full onset of Type 1 Diabetes. This novel drug is available for patients in Stage-2 Type 1 Diabetes as a 1-day infusion series. As part of its ongoing commitment diabetes treatment and prevention, the Barbara Davis Center was the first site in �鶹��ý�� to infuse a patient with Tzield. The Center's new Early T1D Clinic now offer this therapy in addition to screening, monitoring, long-term follow-up, and education as patients navigate the onset of T1D.

Barbara Davis Center (SOM)

CU Anschutz

Barbara Davis Center for Diabetes

1775 North Aurora Court

Aurora, CO 80045

303-724-2323

�鶹��ý��

Tools & Resources

CU Campuses

CU Anschutz Medical Campus

Barbara Davis Center for Childhood Diabetes

School of Medicine

First Patient in �鶹��ý�� Receives New Therapy for Delay of T1d Onset at the BDC

Dr. Satish Garg Speaks About Lower Insulin Prices on CBS News

Smith Lab Hones in on B Cells’ Role in Diabetes

BDC Announcements

Dr. Satish Garg, 2023 Children's Diabetes Foundation Carousel Ball Honoree

Rachel Friedman, PhD; 2023 Spirit of nPOD Award

Maki Nakayama, PhD. Recipient of the 2022 George Eisenbarth Memorial Lecture at the 14th Annual nPOD Meeting

BDC in the News

First Patient in �鶹��ý�� Receives New Therapy for Delay of T1D Onset at the BDC

New Therapy First to Target Type 1 Diabetes Disease Process

First Patient in �鶹��ý�� Receives New Therapy for Delay of T1D Onset at the BDC

New Therapy First to Target Type 1 Diabetes Disease Process

Barbara Davis Center (SOM)

�鶹��ý����

First Patient in �鶹��ý���� Receives New Therapy for Delay of T1d Onset at the BDC

Dr. Satish Garg Speaks About Lower Insulin Prices on CBS News

Smith Lab Hones in on B Cells’ Role in Diabetes

BDC Announcements

Dr. Satish Garg, 2023 Children's Diabetes Foundation Carousel Ball Honoree

Rachel Friedman, PhD; 2023 Spirit of nPOD Award

Maki Nakayama, PhD. Recipient of the 2022 George Eisenbarth Memorial Lecture at the 14th Annual nPOD Meeting

BDC in the News

First Patient in �鶹��ý���� Receives New Therapy for Delay of T1D Onset at the BDC

New Therapy First to Target Type 1 Diabetes Disease Process

First Patient in �鶹��ý���� Receives New Therapy for Delay of T1D Onset at the BDC

New Therapy First to Target Type 1 Diabetes Disease Process

Barbara Davis Center (SOM)

�鶹��ý��

First Patient in �鶹��ý�� Receives New Therapy for Delay of T1d Onset at the BDC

First Patient in �鶹��ý�� Receives New Therapy for Delay of T1D Onset at the BDC

First Patient in �鶹��ý�� Receives New Therapy for Delay of T1D Onset at the BDC